01.03.2022 • NewsAir LiquideBASFIneos

Antwerp@C Project Moves into Engineering

The Antwerp@C project, which aims to halve the Port of Antwerp’s CO2 emissions, has started engineering studies following the completing of a feasibility study last year. The engineering studies will further investigate constructing a central “backbone” throughout the port, along the industrial zones on both the Right and Left Banks of the River Scheldt.

Seven companies are involved in the project, namely Air Liquide, BASF, Borealis, ExxonMobil, Ineos, TotalEnergies and Fluxys. A final investment decision is expected by the end of 2022, once the engineering studies have been finalized.

Jacques Vandermeiren, CEO Port of Antwerp said: “We are very keen to move on to this next phase of engineering studies as this project will contribute to the Flemish, Belgian and European climate goals and to the increased EU 2030 targets for emission reduction to at least 55%.”

In the meantime, Air Liquide, Fluxys and Pipelink – a subsidiary of Port of Antwerp – are mapping initial demand for the CO2 infrastructure.

Also part of the engineering studies is a shared CO2 liquefaction unit with interim storage and marine loading facilities for cross-border shipping. Port of Antwerp said the project would be “among the first and world’s largest multimodal open access CO2 export facilities.”

Author: Elaine Burridge, Freelance Journalist

(c) Port of Antwerp
(c) Port of Antwerp

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.